Tech Company Financing Transactions
Qubit Pharmaceuticals Funding Round
Private investors, OMNES Capital and Quantonation joined a $16.7 million funding round for Qubit Pharmaceuticals. This VC investment round was announced on 6/13/2022.
Transaction Overview
Company Name
Announced On
6/13/2022
Transaction Type
Venture Equity
Amount
$16,700,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to strengthen: its teams, which are expected to rapidly reach 60 people divided between Paris and Boston/
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
201 Rue Lecourbe
Paris, 75015
France
Paris, 75015
France
Phone
Undisclosed
Email Address
Overview
We are a physics driven drug discovery company. Using advanced simulation software and AI-enhanced medicinal chemistry, we develop novel drug candidates and innovative mode of action against challenging targets. We design our drug candidates atom by atom to optimize their efficiency and their specificity with a favorable safety profile at unprecedented speed. We build upon more than 30 years of R&D awarded by the most prestigious prizes such as 2 ERC grants and the ATOS Fourier prize. We spun-off from leading research institutions in France and in the USA : CNAM, CNRS, University of Texas at Austin, Sorbonne University and Washington University, in Saint Louis and we are based in Paris, at the very heart of "Le quartier Latin" and in Boston.
Management Team
Browse more venture capital transactions:
Prev: 6/13/2022: Pixellot venture capital transaction
Next: 6/13/2022: Terra.do venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record tech company VC transactions. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs